MARKET

ADMA

ADMA

Adma Biologics
NASDAQ
15.36
+0.18
+1.19%
Opening 13:27 02/27 EST
OPEN
14.94
PREV CLOSE
15.18
HIGH
15.43
LOW
14.56
VOLUME
2.11M
TURNOVER
--
52 WEEK HIGH
25.67
52 WEEK LOW
13.50
MARKET CAP
3.66B
P/E (TTM)
18.12
1D
5D
1M
3M
1Y
5Y
1D
ADMA Biologics Files Initial Beneficial Ownership Statement for CFO and Treasurer Terry Kohler
Reuters · 19h ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: RxSight (RXST), ADMA Biologics (ADMA) and Soleno Therapeutics (SLNO)
TipRanks · 1d ago
ADMA forecasts $635M revenue for 2026 as ASCENIV drives margin expansion and new supply deals extend growth runway
Seeking Alpha · 1d ago
*ADMA Biologics Names Terry Kohler CFO
Dow Jones · 1d ago
*ADMA Biologics Announces Retirement of Brad Tade as CFO
Dow Jones · 1d ago
ADMA BIOLOGICS INC: TADE WILL SERVE AS A CONSULTANT TO THE COMPANY
Reuters · 1d ago
ADMA Biologics Announces CFO Transition and Leadership Change
TipRanks · 2d ago
ADMA Biologics FY 2025 revenue up 20% on ASCENIV sales
Reuters · 2d ago
More
About ADMA
ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The Company manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV (immune globulin intravenous, human-slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM (immune globulin intravenous, human) for the treatment of PI; and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.

Webull offers ADMA Biologics Inc stock information, including NASDAQ: ADMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADMA stock methods without spending real money on the virtual paper trading platform.